We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Analyses the impact of regenerative medicine research internationally and in the United Kingdom. Aims to map the global landscape of regenerative…
How to distinguish between products that are regulated as medical devices and those regulated as medicinal products.
The following detailed requirements shall apply to veterinary medicinal products other than biological veterinary medicinal products, except where otherwise set out in Section IV.
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
Updates a patent analysis of regenerative medicine from 2006 analysis by the Intellectual Property Office for BIS. It is specifically based …
An update regarding the European Commission's Working Group meeting on nutrition and health claims,17 September 2012, was issued to interested parties on the 25 September 2012.
Requirements for Immunological Veterinary Medicinal Products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).